Incontinence Drug Ruling Offers Key Patent Drafting Lessons
IP Law 360
NOVEMBER 2, 2023
Teva and Sandoz, an English court found that the patent for a drug used to treat overactive bladder syndrome had not been infringed, highlighting the interaction between patent drafting and litigation strategy, and why claim infringement is as important a consideration as validity, George McCubbin at Herbert Smith.
Let's personalize your content